Nucleic Acids and Precision Therapies for Neuroprotection
Samenvatting
Neurodegenerative disorders are rising, yet most drugs temper symptoms. Nucleic Acids and Precision Therapies for Neuroprotection addresses this therapeutic shortfall directly, tracing how antisense oligonucleotides, RNA interference agents, mRNA platforms, aptamers, and CRISPR-class editors are redefining what “treatable” means.

